SCHEMBL4827487

SCHEMBL4827487

Cc1c(C(=O)O)cnn1-c1nc(-c2ccc3ccccc3c2)cs1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.77
KDM4E B2RXH2 4/20 0.53
ALDH1A1 P00352 3/20 0.53
RAB9A P51151 8/20 0.53
MEN1 O00255 7/20 0.53
KMT2A Q03164 7/20 0.53
NPC1 O15118 6/20 0.53
CRHBP P24387 1/20 0.53
MC4R P32245 1/20 0.53
CRHR2 Q13324 1/20 0.53
ATM Q13315 1/20 0.53
ITGB2 P05107 1/20 0.49
ICAM1 P05362 1/20 0.49
ITGAL P20701 1/20 0.49
GAA P10253 2/20 0.48
MAPT P10636 2/20 0.48
HPGD P15428 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14196468 0.89 RAB9A (0.60) PTGER4KDM4EALDH1A1RAB9AMEN1
SCHEMBL12875465 0.88 RAB9A (0.63) PTGER4KDM4EALDH1A1RAB9AMEN1
SCHEMBL12875489 0.85 KDM4E (0.60) PTGER4KDM4EALDH1A1RAB9AMEN1
SCHEMBL6255206 0.85 RAB9A (0.58) PTGER4KDM4EALDH1A1RAB9AMEN1
SCHEMBL1198595 0.84 MEN1 (0.72) PTGER4KDM4EALDH1A1RAB9AMEN1
SCHEMBL14196464 0.84 MEN1 (0.57) PTGER4KDM4EALDH1A1RAB9AMEN1
SCHEMBL4821930 0.83 KDM4E (0.58) PTGER4KDM4EALDH1A1RAB9AMEN1
SCHEMBL12875487 0.83 KDM4E (0.76) PTGER4KDM4EALDH1A1RAB9AMEN1
SCHEMBL12875461 0.83 KDM4E (0.58) PTGER4KDM4EALDH1A1RAB9AMEN1
SCHEMBL12875471 0.83 RAB9A (0.72) PTGER4KDM4EALDH1A1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7358267-B2 Bis-aryl thiazole derivatives AMGEN INC. (US) 2008-04-15 US disclosed
US-7358267-B2 Bis-aryl thiazole derivatives AMGEN INC. (US) 2008-04-15 US disclosed
US-7358267-B2 Bis-aryl thiazole derivatives AMGEN INC. (US) 2008-04-15 US disclosed
US-20050215608-A1 Bis-aryl thiazole derivatives AMGEN INC. 2005-09-29 US disclosed
WO-2003002062-A2 BIS-ARYL THIAZOLE DERIVATIVES TULARIK INC. (US) 2003-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215608-A1 Bis-aryl thiazole derivatives FABP4, PC, TXNRD2 PTGER4 1957/4885KDM4E 3696/4885ALDH1A1 842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.